Quick Answer
NovaBridge Biosciences reported Operating Income of -$51.43 million for fiscal year 2024.
NovaBridge Biosciences Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2024 | -$51.43M | +28.6% |
| 2023 | -$72.02M | -35.7% |
| 2022 | -$53.08M | — |
- NovaBridge Biosciences showed an increase of +28.6% in Operating Income compared to the prior fiscal year.
- Over the 2022–2024 period, NovaBridge Biosciences’s operating income has grown by 3.1% (from -$53.08 million to -$51.43 million).
- The most recent figure is from NovaBridge Biosciences’s fiscal year 2024 report (Form 20-F), filed with the SEC on April 3, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: